Before the arrival of the Corona vaccine, the Priority Group has been finalized in India. In the first phase, 31 crore people will be vaccinated. These include healthcare workers, police, priority group members above 50 years of age, and youth from high-risk groups. The government has also decided that the initial data from two full-shot results from two-dose trials of the Oxford-AstraZeneca vaccine will be considered.
Blueprint for vaccine preparation
Principal Scientific Advisor K. According to Vijayaraghavan, the National Vaccine Committee headed by Dr. VK Paul has prepared a blueprint for who will be the first to be vaccinated. He told a meeting of the Ministry of Science and The Confederation of Indian Industry (CII) that 31 crore people have been identified, who will be vaccinated between March and May.
Vijayaraghavan said, 'One crore health workers in our country, 2 crore of state and central government police, armed forces, home guards, civil defense, 26 crore members of priority group over 50 years of age and below 50 years 1 crore members of the high-risk group will be the first to be vaccinated. Earlier, Union Health Minister Harsh Vardhan has said that the vaccine will start from the first quarter of 2021. 25 crore people are ready to be vaccinated. 40-50 crore doses will be available by July.
What data will Oxford consider India?
Phase 3 or final phase trials of the Corona Vaccine Coveshield of Oxford University-AstraZeneca have yielded results. On giving two full doses, the FICCI was 62% and when given one half and one full dose, the FICC was 90 percent. On which of these two formulas the data will be considered in India, the head of the National Vaccine Committee, Dr. VK Paul has said that the regulators are examining the data. Whatever decision will be taken will be on a scientific basis. It is not right to make public debate on this data is confidential. At the same time, some other Indian officials say that the American Food and Drug Administration (USFDA) has required at least 50% efficacy to approve the vaccine. In this case, the results of two full dosage formulas are also good.
European Union will take its first vaccine this year
European Union leaders expect the first vaccine to be introduced in December. By the way, the European Medicines Agency, without naming any company, said that in the next few days, some companies can apply for approval. Pfizer and Biotech are at the forefront of the regulatory approval process. Apart from Pfizer, American company Moderna and British company AstraZeneca and Oxford University have also announced the results of Phase-3 trials of their vaccine. Pfizer has also applied for approval in the US. The process of applying the vaccine to high-risk patients has already started even before the results of Phase-3 trials in China and Russia. For this, China has given emergency approval to four vaccines and Russia two.
UK regulator will investigate the results of the Oxford vaccine
The British government has formally asked the country's drug regulator to examine the Phase-3 results of AstraZeneca and Oxford University's vaccine-Kovyshield. The British government has taken this step amid questions arising over the initial results of the trials. Earlier, the UK government had also instructed the medical regulator to check the efficacy of Pfizer's vaccine. The drug regulator says that any vaccine will be approved even after meeting the criteria on the issue of safety, quality, and affixation.
AstraZeneca will conduct a new global clinical trial
AstraZeneca said it would conduct a global clinical trial to see its vaccine affixation. However, regulatory approval in the UK or EU will not be delayed. There may be a delay in seeking approval from the USFDA for vaccines in the US. During the trials, 2,741 volunteers received half + one dose, while 8,895 people received two full doses. In such a situation, the company faced difficulties in proving effectiveness in the group.
Russian vaccine will remain effective with Oxford vaccine
Russia's Gamalaya Research Institute has claimed that its Sputnik V vaccine may increase Astyzyneca-Oxford's CoviShield's Efficacy. Gamalaya Institute said on social media - "Oxford's two full dose affixes have been 62%. If new clinical trials begin, we suggest Sputnik V Human Adenoviral Vector Shot with Kovyshield, this will increase the Efficiency Two. Adding the vaccine can lead to significant re-vaccination results. "
Pfizer vaccine will be approved in Canada in December
Canadian drug regulator, Health Canada, has said it will approve Pfizer-BioNotech's COVID-19 vaccine around December. Supriya Sharma, Senior Medical Advisor at Health Canada, said that the vaccine has been at the forefront of Health Canada's review. A final decision on Pfizer's vaccine may also be taken in Canada's neighboring country of America in December and it can be approved for emergency use.
India said in the United Nations, we have sent more than 40 thousand metric tons of wheat to Afghanistan so far
India has so far shipped over 40,000 metric tonnes of wheat to Afghanistan, ensuring its status as Kabul's immediate neighbor and long-standing partner. Ruchira Kamboj, the country's Permanent
World Cup 2023: New Zealand's pride broken in Dharamsala, India ends 20-year drought in ICC tournaments; These are the 5 heroes of victory
The Indian team defeated New Zealand by four wickets with 12 balls remaining in the 20th match of the World Cup 2023 on Sunday. This was the fifth consecutive win in the tournament for the Rohit
KVS Admissions 2022: The last date for first-class admission application in Kendriya Vidyalayas today, apply soon
Kendriya Vidyalaya KVS Class 1 Admission 2022: If you also want to enroll your beloved or beloved in Kendriya Vidyalaya, then this news is very important for you. The admission process for KVS 1st
Taliban's new decree: Shopkeepers will not sell products to women without hijab; Action will be taken if the order is not followed
A new decree has been issued in the Taliban for women who do not wear hijab. In Afghanistan's Balkh province, shopkeepers have been forbidden from selling anything to women without a hijab. According
Blood clotting cases are very low after getting vaccinated in the country, so far only 26 cases have been found
There are very few cases of blood clotting after vaccination against the Covid-19 epidemic in India, and the number is as high as possible estimates in the country. This information was revealed in a
ED Attaches PFI Accounts: ED attaches bank accounts of PFI, action in money laundering case
The Enforcement Directorate (ED) on Wednesday said it has attached Rs 68.62 lakh of money laundering charges belonging to Islamic outfit PFI and its forward organization Rihab India Foundation. The
Virat Kohli's followers on Instagram: The figure crosses 20 crores, the first cricketer in the world to have so many followers, earns 5 crores from every post
Former Indian captain Virat Kohli\'s bat may be silent on the field, but he is collecting a lot of fours and sixes on social media. In the last two years, his bat did not score a century in any
Is India walking on the edge of the sword regarding relations with Russia and America?
After the situation arising after Russia attacks Ukraine, if any country is facing the biggest challenge then it is India. This is to say the experts of foreign and strategic affairs.
Demand: Kejriwal demands to make vaccine formula public, says other companies should also make vaccines
Delhi Chief Minister Arvind Kejriwal on Tuesday held a digital press conference. During this, he said that more than three lakh people will be given vaccines daily. He also said that the formula for
Delhi: Initiative of IIT Delhi, Kanpur, and Bombay - Internship will be done for engineering, science, and maths students of Ladakh
IIT will help in connecting the students of Ladakh, the Union Territory of Jammu and Kashmir, from higher education to employment. Under the guidelines of Prime Minister Narendra Modi, the country's
